Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
KRYS
$305.23
-0.15%
KRYS
· Krystal Biotech, Inc.
$305.23
-0.45 (-0.15%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$9.05B
Shares
29.63M
Volume · Nov 13
110.29K
Avg daily vol (3M)
280.28K
All webcasts
Earnings call · FY2024 Q2
Krystal Biotech, Inc. (KRYS) Q2 2024 Earnings Call
Revenue
$70.28M
Diluted EPS
$0.53
Net income
$15.57M
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 5, 2024.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Non-GAAP combined Research and Development and Selling, General
year ending December 31, 2024
|
$150M – $175M | Non-GAAP |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 5, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 5, 2024 · complete as-filed document